Team HBV was formed in 2006 with a mission to raise awareness of the disproportionately high incidence of HBV and liver cancer in the API community through community outreach and the global Jade Ribbon Campaign (JRC) Statistics about HBV and Liver Cancer
--HBV Threat--
•HBV can survive outside of body for 7 days, as opposed to a few hours for HIV, making HBV 50x-100x more infectious than HIV (WHO
)
•As many as 2 out of 3 chronically infected are not aware of the infection due to lack of symptoms
•Those chronically infected have a 200x greater risk of developing liver cancer than uninfected (Jenkins et al., 2001)
•1 in 4 will die from HBV-related liver cancer or cirrhosis if not treated (WHO, 2000)
•If liver cancer is diagnosed late, 5-year survival rate is about 5%-7% (SEER)
•Over 50% of all liver cancer is caused by chronic HBV (Global Health Epidemiologist)
•Those infected via birth have a 90% chance of becoming chronic carriers, compared to 10% if infected in adulthood (ALC)
•90% of infants infected during the 1st year of life develop chronic HBV (WHO)
•30-40% of children infected during 1-4 years of life develop chronic HBV (WHO)
•About 25% of children who become infected with hepatitis B would die from hepatitis B related liver cancer or cirrhosis as adults (CDC)
--Worldwide Threat--
•1/3 of world population (2 billion people) have been infected with HBV (WHO)
•1/20 of world population (400 million people) have chronic HBV, which is 10x more prevalent than HIV/AIDS (WHO)
•1 in 12 people worldwide are living with either chronic HBV or HCV (World Hepatitis Alliances)
•About 620,000- 1 million people worldwide die from HBV –related liver disease and liver cancer each year (CDC), which is equals to 1 person dying every 30-45 seconds from the vaccine-preventable HBV (ALC)
•1,645 people die from liver cancer worldwide each day (ALC)
•Liver cancer is in the top 5 leading causes of death by cancer worldwide (WHO)
•An global epidemiology of HBV infection has been studied in primary literatures. (Ex: Global Epidemiology of Hepatitis B Virus- Custer et al, 2004; http://www.cdc.gov/hepatitis/HBV/PDFs/ChronicHepBTestingFlwUp.pdf).
--Threat in Asia--
•2/3 of the chronically infected live in Asia, with 130 million in China alone
•10% Asians and Pacific Islanders worldwide have HBV
•Some regions of Asia have a higher prevalence, reaching up to 15%-20% of the local population
•Compared to 10% Asians, only 0.1% Caucasians, 0.1% Hispanics, and 0.5% African Americans are chronically infected with HBV; Asians are 100 x more likely to get HBV than whites
--Threat in the U.S.--
•About 12.5 million Americans have been infected with hepatitis B at some point in their lifetime (CDC).
•About 1.2 million Americans have chronic HBV (CDC)
•One out of every 20 people in the U. will become infected with HBV sometime during their lives (hep foundation international)
•10% (1 in 10) Asian Americans have chronic HBV, compared to less than 0.5% (1 in 1000) in the general U.S. population (CDC)
•Liver cancer is one of the greatest health disparities in Asian Americans (SEER)
•1.4 million Americans have chronic HBV, that is 3-4 x more than HIV/AIDS
•5,000 people die from HBV-related liver cancer or cirrhosis with liver failure each year (CDC, 2005)
•Chronic HBV causes 80% of primary liver cancer, which is the 2nd leading cause of death by cancer for Asian American men. (SEER, NIH, American Caner Association, US Statistics Working Group, 2005)
•Liver cancer is the 7th leading cause of cancer death in API women (US Statistics Working Group, 2005)
•Liver cancer in Asian American men is 9x more likely than in white men.
•Among API men living in California, liver cancer ranks as a leading cause of cancer death: #1 for Laotian Americans, #2 for Vietnamese and Cambodian Americans, #4 for Chinese and Korean Americans, and #5 for Filipino Americans (ALC).
•Medical cost and work loss cost for HBV-related conditions total more than $700 million per year in U.S. The greatest decline has occurred among children and adolescents due to routine hepatitis B vaccination (CDC)
•About 16,000 - 20,000 hepatitis B infected women give birth each year (CDC).
•About 1/3 of chronic hepatic B were infected in perinatal and early childhood (CDC)
•Foreign born API American pregnant women have an estimated incidence of infection of 8.9%, whereas their white counterparts have an estimated incidence of 0.13%
